Stay updated on Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page
- Check6 days agoChange DetectedEnrollment status now indicates that recruitment has closed. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and there were minor header/revision text updates.SummaryDifference0.1%

- Check14 days agoChange DetectedThe site's revision marker changed from v3.5.4 to v3.5.5, indicating an updated release of the platform. This change does not modify the study page content.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision tag was updated to v3.5.4, representing a minor update to the study record rather than a substantive change to its content.SummaryDifference0.0%

- Check56 days agoChange DetectedUpdated the Chile site’s location labeling (Araucania/Temuco) by replacing Spanish “Región de la Araucanía” wording with “Araucania,” and updated the page’s revision footer from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.